Transdermal Treatment Options for Neurological Disorders
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 23 (5) , 357-375
- https://doi.org/10.2165/00002512-200623050-00001
Abstract
No abstract availableKeywords
This publication has 120 references indexed in Scilit:
- Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatmentJournal of Controlled Release, 2004
- Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain ScaleCurrent Medical Research and Opinion, 2004
- Review of Lidocaine Patch 5% Studies in the Treatment of Postherpetic NeuralgiaDrugs, 2004
- Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatmentNeurological Sciences, 2003
- Transdermal Administration of Piribedil Reverses MPTP-induced Motor Deficits in the Common MarmosetClinical Neuropharmacology, 2000
- Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's diseaseMovement Disorders, 1998
- Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neuronsLife Sciences, 1994
- TacrineDrugs & Aging, 1994
- Pharmacokinetic Characterisation of Transdermal Delivery SystemsClinical Pharmacokinetics, 1994
- Clinical Pharmacokinetics of Anti-Parkinsonian DrugsClinical Pharmacokinetics, 1987